These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 9823951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multiparameter flow-cytometric analysis of bcl-2 and Fas expression in normal and neoplastic hematopoiesis.
    DiGiuseppe JA, LeBeau P, Augenbraun J, Borowitz MJ.
    Am J Clin Pathol; 1996 Sep; 106(3):345-51. PubMed ID: 8816592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
    Inaba H, Shimada K, Zhou YW, Ido M, Buck S, Yonehara S, Kaplan J, Komada Y.
    Int J Oncol; 2005 Aug; 27(2):573-9. PubMed ID: 16010441
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas.
    Cerrato JA, Khan T, Koul D, Lang FF, Conrad CA, Yung WK, Liu TJ.
    Int J Oncol; 2004 Feb; 24(2):409-17. PubMed ID: 14719118
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines.
    Lam V, Findley HW, Reed JC, Freedman MH, Goldenberg GJ.
    Leuk Res; 2002 May 15; 26(5):503-13. PubMed ID: 11916527
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene.
    Zhou M, Yeager AM, Smith SD, Findley HW.
    Blood; 1995 Mar 15; 85(6):1608-14. PubMed ID: 7888679
    [Abstract] [Full Text] [Related]

  • 17. Ceramide-induced apoptosis in fas-resistant Hodgkin's disease cell lines is caspase independent.
    Metkar SS, Anand M, Manna PP, Naresh KN, Nadkarni JJ.
    Exp Cell Res; 2000 Feb 25; 255(1):18-29. PubMed ID: 10666330
    [Abstract] [Full Text] [Related]

  • 18. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U, Wagenknecht B, Naumann U, Weller M.
    Cell Physiol Biochem; 1999 Feb 25; 9(1):29-37. PubMed ID: 10352342
    [Abstract] [Full Text] [Related]

  • 19. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex.
    Medema JP, Scaffidi C, Krammer PH, Peter ME.
    J Biol Chem; 1998 Feb 06; 273(6):3388-93. PubMed ID: 9452459
    [Abstract] [Full Text] [Related]

  • 20. Fas-mediated apoptosis in human prostatic carcinoma cell lines.
    Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB.
    Cancer Res; 1997 May 01; 57(9):1758-68. PubMed ID: 9135020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.